Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination With Oseltamivir, in Adults With COVID-19

NCT04516915 is registered in ClinicalTrials.gov with University Hospitals Coventry and Warwickshire NHS Trust as lead sponsor.

NCT NCT04516915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04516915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination With Oseltamivir, in Adults With COVID-19
Lead sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Phase
Phase 2
Overall status
Completed
Start date
June 15, 2020
Completion date
September 21, 2022
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19